None listed
Conditions
Interventions
None listed
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with the following lymphoid malignancies through histopathological diagnostic procedures, regardless of whether they were previously treated: 1) Hodgkin lymphoma 2) B-cell non-Hodgkin lymphoma 3) T or NK cell non-Hodgkin lymphoma 4) Diseases included in the category of lymphoid malignancies in other WHO classifications 2. Patients over 20 years of age 3. Patients who gave written consent to participate in a prospective cohort study
Exclusion criteria
Exclusion criteria: 1. In case of malignant tumor of the lymphatic system that falls under any of the following diseases: yes; Plasma cell disease, amyloidosis 2. If you are a patient with the following lymphatic malignancies: 1) In case of follow-up observation after diagnosis because treatment is not necessary 2) When only local radiation therapy is planned for the purpose of anticancer treatment 3) When using only antiviral drugs, antibiotics, or steroids rather than anticancer drugs for the purpose of anticancer treatment 3. Patients who do not understand or do not agree to written consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Factors associated with treatment response and survival (Response rate to first-line treatment administered after registration, Response rate to rescue treatment administered after disease recurrence or progression, overall survival rate, Progression-free survival) | — |
Secondary
| Measure | Time frame |
|---|---|
| Serious adverse events and serious and unexpected adverse drug events | — |
Countries
Korea, Republic of
Contacts
Public Contactdanbee Kang
Samsung Medical Center
Outcome results
None listed